Early response evaluation using multiparametric high-field MRI in locally advanced rectal cancer under neoadjuvant chemoradiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00025258

Enrollment

Registered

2021-06-10

Start date

2015-04-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C20

Interventions

Group 1: neoadjuvant radiochemotherapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with initial diagnosis of rectal cancer in clinical stages T3, T4 and N +

Exclusion criteria

Exclusion criteria: MRI contraindications

Design outcomes

Primary

Measure	Time frame
To determine the smallest parameter set that is sufficient for decision-making and to derive a prognosis score from it.	—

Secondary

Measure	Time frame
histopathological processing of the surgical specimens	—

Countries

Germany

Contacts

Public ContactArndt-Oliver Schäfer

Klinikum St. Georg gGmbH

Arnd-Oliver.Schaefer@sanktgeorg.de+49(0)341 909-2700

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026